Clinical trial Talapro-3
Talapro-3: A Phase 3, Randomized, Double-Blind, Study Of Talazoparib With Enzalutamide Versus Placebo With Enzalutamide In Men With Ddr Gene Mutated Metastatic Castration-Sensitive Prostate Cancer
Cancers | |
---|---|
Organ | prostate |
Trial status | Trial closed for recruitment |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 3 |
Academic trial | Non |
Sponsor | Pfizer |
EudraCT Identifier | 2021-000248-23 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04821622 |
Last update |